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Effect of Methylprednisolone in Peri-articular 1 
Infiltration for Primary Total Knee 2 
Arthroplasty on Pain and Rehabilitation 3 
A PROSPECTIVE COMPARATIVE STUDY 4 
Abstract: 5 
Background: Optimal pain management post-total knee arthroplasty is important 6 
to ensure timely rehabilitation and patient satisfaction. This study examines the 7 
efficacy of adding corticosteroid in peri-articular infiltration cocktail with relation 8 
to post-operative pain management and rehabilitation in patients undergoing 9 
simultaneous bilateral total knee arthroplasty. 10 
Methods: 50 patients with symptomatic end-stage bilateral knee osteoarthritis 11 
undergoing bilateral TKA under the same anaesthetic were recruited. More 12 
painful knee was operated first and the study solution containing ropivacaine, 13 
clonidine, epinephrine, and ketorolac with methylprednisolone was infiltrated in 14 
one knee and an identical mixture but without methylprednisolone was infiltrated 15 
in the second knee. Outcome measures included comparison of VAS on 16 
movement of each knee and range of motion achieved during the first three days 17 
post-surgery. 18 
Results: Difference of VAS score and ROM at day one and three between the two 19 
groups of knees were significant (p<0.05). Post-operative inflammation as well as 20 
ability to straight leg raise showed better trends in the knees receiving 21 
prednisolone although this did not reach statistical significance. 22 
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Conclusion: Addition of Methylprednisolone to periarticular infiltration cocktail 23 
for patients undergoing TKA has significant influence on reduction of pain in early 24 
post-operative period and patients are able to regain knee flexion more quickly. 25 
 26 
Key Words: Periarticular infiltration, Methylprednisolone, Post-operative Pain, 27 
Range of motion, Total Knee Arthroplasty. 28 
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Introduction: 47 
Total knee arthroplasty (TKA) is established as treatment of choice for end-stage 48 
symptomatic knee osteoarthritis (OA). It provides reliable function and implant 49 
survival is reported at around 95% at 10 years
1,2
. One key unresolved issue is post-50 
operative pain in the peri-operative period. Effective post-operative pain relief 51 
helps early rehabilitation, prevention of deconditioning, and timely discharge to 52 
ensure optimal outcomes and make resources more available. Pain has been 53 
shown to be one of the main clinical reasons for hospital stay after knee 54 
arthroplasty and finding the best post-operative pain control regimen is at the top 55 
of priority setting partnerships
3
.  56 
Intra-operative peri-articular infiltration is routinely used to reduce the intensity 57 
and severity of post-operative pain
4,5,6,7 
. This infiltration typically contains a 58 
mixture of various agents including a local anaesthetic, an anti-inflammatory 59 
agent and epinephrine. In addition, use of intermediate acting
 
corticosteroid such 60 
as Methylprednisolone is recommended by some experts due to its anti-61 
inflammatory properties
8, 9, 10
. However, use of corticosteroids can increase the 62 
risk of infection and therefore not routinely used in the peri-articular filtration. 63 
At present, there is no consensus about the use of corticosteroids in the peri-64 
operative period following knee arthroplasty. In addition, the intensity of post-65 
operative pain after surgery varies among different patients. It not only depends 66 
upon patient factors but also upon surgeon factors. It is difficult to control for 67 
various confounders to establish whether indeed addition of a corticosteroid to 68 
local infiltration is safe and effective. One way to overcome this is to assess the 69 
impact in a cohort of patients who undergo bilateral TKA performed by the same 70 
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surgeon using the same surgical technique under the same anaesthetic. This study 71 
aims to compare the safety and efficacy of adding a corticosteroid to the peri-72 
articular infiltration in patients undergoing single-stage bilateral TKA.    73 
Materials and Methods: 74 
This prospective non-randomized study was conducted over a nine month period 75 
(September 2017 to June 2018). Institutional scientific advisory committee and 76 
ethical committee approval was duly obtained and all patients consented to 77 
taking part in the study. 50 patients with bilateral symptomatic end-stage knee 78 
OA listed for single staged bilateral TKA were approached. Eligible patients were 79 
aged between 50 and 80 years. Patients with any of the following were excluded 80 
from the study: poorly controlled Diabetes (HbA1C > 7.0), history of inflammatory 81 
arthritis, renal insufficiency (eGFR<90 mL/min per 1.73m
2
), hypersensitivity to the 82 
study drug, prolonged QT interval in ECG and/or patients with history of knee 83 
infection were excluded from the study. 84 
Pre-operative knee range of motion was documented. Patients were asked about 85 
the more painful knee pre-operatively. All patients received similar pre-operative 86 
medications which included 650 mg of oral Paracetamol and 100 mg of oral 87 
Gabapentin on the previous night of surgery and at 2 hours before surgery. All the 88 
patients received spinal anaesthesia with plain 0.5% Bupivacaine and 500 mg of 89 
systemic Tranexamic acid was given pre-operatively, and in addition three hours 90 
and six hours from the time of first dose. 91 
Ropivacaine was the long acting local anaesthetic used in the cocktail along with 92 
Epinephrine to prolong its action. Clonidine being an alpha-2 receptor agonist acts 93 
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on C and Aδ fibers, and decreases the conduction to prolong the action of local 94 
anesthetic and also through vasoconstrictor effect which reduces the drug wash-95 
out from perineural tissues. Ketorolac is the adjuvant NSAID in the cocktail. 96 
All patients underwent single stage bilateral TKA. More painful knee was operated 97 
first and received methylprednisolone which was added to the peri-articular 98 
infiltration (study group: Group S). The second knee received peri-articular 99 
infiltration identical to the first except the methylprednisolone (Group C). The 100 
surgeries were performed by either of the two senior surgeons (MK or HW). All 101 
surgeries were performed under tourniquet control with a standard midline 102 
incision and a medial parapatellar arthrotomy. Posterior stabilized prosthesis was 103 
used in all patients and in none of the cases patella was resurfaced. Patellar 104 
osteophyte excision with circumferential denervation was done with diathermy. 105 
After preparation of the bony surfaces and just prior to cementation of the 106 
definitive TKA components the  solution containing ropivacaine, clonidine , 107 
epinephrine, and ketorolac (details of dosage provided in table 1) with one ml of 108 
methylprednisolone(40 mg) was infiltrated in the peri-articular tissues using a 109 
standardized protocol in the first knee and similar procedure was repeated for the 110 
second knee with the infiltration used being identical to the first solution except 111 
methylprednisolone. Infiltrated sites in order being posterior capsule, medial and 112 
lateral meniscal bed, synovium, iliotibial band, collateral ligaments before 113 
cementing and quadriceps, retinaculum, patellar tendon after implanting the 114 
components. Tourniquet was released and haemostasis achieved before closing 115 
the joint. No drain was used. 116 
 117 
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DVT chemoprophylaxis included 40mcg of sub cutaneous low molecular weight 118 
heparin for five days post operatively followed by oral Rivaroxaban 10mg for 119 
fourteen days. Patients were also provided with below knee anti-embolism 120 
compression stockings to be used in the post-operative period for six weeks.  121 
 122 
Patients were encouraged to stand with support on the same day of surgery and 123 
used ice packs to both the knees four times a day during their hospital stay. 124 
Patients received six hourly intravenous (IV) Paracetamol 1g along with twelve 125 
hourly IV Tramadol 50 mg and Diclofenac 75 mg post-operatively for the first 48 126 
hours post-surgery. Later, PRN oral analgesics were prescribed (Paracetamol and 127 
tramadol). All patients received standard DVT chemoprophylaxis for first two 128 
week post-surgery.  129 
 130 
Pain on movement was recorded separately for each knee as VAS (Score 0 -10; 0 - 131 
No pain; 10 - worst pain) at 24 hours and 72 hours post-surgery. Active range of 132 
motion (ROM) was measured with a goniometer on post-operative day one and 133 
day three. Time for straight leg raise in both lower limbs and appearance of any 134 
ecchymosis/inflammation were documented. Patients were assessed for any local 135 
(hypersensitivity reaction, infection, bleeding or tendon rupture) or systemic 136 
(cardiovascular issues, renal impairment, stroke) adverse events. All assessments 137 
were conducted by an independent blinded observer who was not a part of 138 
operating team. The assessor did not know the order in which surgeries were 139 
performed (or which knee received which peri-articular injection). The assessor 140 
asked questions about either knee in a random sequence. All patients were 141 
assessed at 2 weeks post-surgery, at one month and contacted a 6 months post-142 
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surgery to check if they needed any further intervention or treatment for their 143 
bilateral TKAs. Methylprednisolone knee was identified with data in operative 144 
records showing the first operated knee. 145 
 146 
Statistical analysis: 147 
Baseline data, range of motion and VAS scores at first day and third day post-148 
surgery were compared using paired T test. Categorical data was compared using 149 
chi-squared test. All analysis was performed using SPSS (IBM SPSS statistics 150 
version 20) with p < 0.05 deemed statistically significant.  151 
 152 
 153 
 154 
 155 
Results: 156 
Mean age of patients was 67 years (range: 53 - 82, SD 7.5) of which 13 were males 157 
and 37 were females. The two groups were well matched for pre-operative 158 
flexion deformity, further flexion and surgical time (table 2).  159 
 160 
No patient died in the first six months post-surgery. No patient was lost to follow 161 
up and none of the patients needed any further intervention related to their 162 
replaced knees. At six months follow up none of the patients included in study 163 
had suffered from superficial or deep infection in either of the knees. 164 
 165 
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The mean VAS at 24 hours post-surgery was 2.9 (range: 1 - 6, SD 1.2) and 4.6 166 
(range: 2 - 6, SD 1.0) for group S and group C respectively.  The difference 167 
between the two groups was statistically significant (p <0.05).  The mean VAS at 168 
72 hours post-surgery was 2.0 (range: 1 - 4, SD 0.9) and 3.5 (range: 1 - 6, SD 1.0) 169 
for group S and group C respectively.  The difference between the two groups was 170 
statistically significant (p <0.05). 171 
 172 
The mean ROM at 24 hours post-surgery was 67
0
 (range: 30
0
 - 90
0
, SD 13.7) and 173 
55
0
 (range: 30
0
 - 80
0
, SD 12.1) for group S and group C respectively.  The 174 
difference between the two groups was statistically significant (p <0.05).  The 175 
mean ROM at 72 hours was 80
0
 (range 50
0
 - 100
0
, SD 12.0) and 72
0
 (range: 50
0
 - 176 
90
0
, SD 12.0) for group S and group C respectively.  The difference between the 177 
two groups was statistically significant (p <0.05). Inflammatory signs (redness, 178 
edema and tenderness) were present in 9 knees with steroid infiltration 179 
compared with 17 knees without steroid. The difference was non-significant (p > 180 
0.05). The mean time to achieve straight leg raise was 3.3 days (range:  1 - 4, SD 181 
0.8) for group S as compared to 3.6 days (range: 2 - 4, SD 0.6) for group C. The 182 
difference between the two was non-significant (p > 0.05).  183 
 184 
Discussion: 185 
 186 
This study has shown that addition of 40 mg of methylprednisolone in the peri-187 
articular infiltration for patients undergoing TKA is effective in terms of reducing 188 
pain at least for the first 72 hours post-surgery and also helps to regain knee 189 
flexion more quickly. It is the first study in patients undergoing simultaneous 190 
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bilateral TKA under the same anaesthetic using same surgical technique by the 191 
same surgeon comparing the use of steroid in the local infiltration.  192 
 193 
Corticosteroid is an established post-operative pain control drug via systemic 194 
routes
11
. Intra articular use of corticosteroids in knee osteoarthritis management 195 
has been studied extensively both for benefits and complications
12, 13
. Studies 196 
related to periarticular use of the drug are limited. The aim of our study was to 197 
compare the effect of using a corticosteroid in periarticular infiltration solution 198 
with reference to its effect in post-operative pain control. This study compared 199 
the effect with periarticular infiltrations between the knees of same patient. This 200 
greatly reduced bias of the subjective difference in pain perception as it occurs of 201 
different patients. Many previous studies have shown the beneficial effects
14, 15, 16
 202 
of corticosteroid in the infiltration cocktail with some reporting complications
17
 203 
related to its use. Our study showed statistically significant improvement in VAS 204 
score and knee flexion on day one and three between two groups. The use of 205 
steroid in the infiltration helped patients achieve straight leg raise more quickly 206 
and the incidence of post-operative inflammation was less although the 207 
differences were not statistically significant. 208 
 209 
The study
17
 conducted by Christian P. Christensen et al. with two different groups 210 
for steroid and without steroid infiltration (steroid: 37 patients, no steroid: 39 211 
patients) suggested that the addition of a corticosteroid to intraoperative 212 
periarticular injections does not provide benefit when compared with injections 213 
that do not contain a corticosteroid. They also reported complications like deep 214 
knee joint sepsis and requirement of manipulation under anaesthesia at nine 215 
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weeks post knee replacement surgery in steroid patients group. However our 216 
study did not encounter any such complications during the study period. 217 
 218 
Sae Kwang et al. conducted a study
18
 with 76 patients who underwent sequential 219 
bilateral TKA with an interval of three months between the two surgeries. In this 220 
study, one knee was randomly assigned to the steroid (40 mg triamcinolone 221 
acetonide) or non-steroid peri-articular infiltration group. After 3 months, the 222 
contralateral knee was assigned to the opposite group. Patients were assessed for 223 
nighttime pain, functional recovery [straight leg raising (SLR) ability and maximal 224 
flexion], patient satisfaction, and complications during the post-operative period. 225 
Authors reported significantly lower pain level in the steroid than the non-steroid 226 
group on the night of the operation (VAS, 1.2 vs. 2.3; p=0.021). No significant 227 
differences were reported in maximum flexion between the two groups although 228 
the authors did notice earlier ability to achieve straight leg raise in the steroid 229 
group. S. Tsukada et al. conducted a double blind randomized control study
10
 with 230 
total of 77 patients. They noticed that the corticosteroid group had a significantly 231 
lower cumulative pain score than the no corticosteroid group during the first 24 232 
hours after surgery (p = 0.024). The rate of complications, including surgical site 233 
infection, was not significantly different between the two groups up to one year 234 
postoperatively. In a study
19
 conducted by Chia et al. they concluded that 235 
injecting steroid to the extensor mechanism has the risk of delayed tendon 236 
rupture. In our study also infiltration of steroid into extensor mechanism was 237 
avoided. Probably owing to that, post operatively no difference was noticed in 238 
number of days required by the patient to perform straight leg raising. 239 
 240 
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This study has certain limitations. Period of post-operative follow up is short and 241 
range of motion and pain scores beyond third day were not compared between 242 
two groups. As the effect of methylprednisolone is unlikely to last after 72 hours, 243 
we do not expect any difference in pain scores or ROM in the long-term although 244 
this needs to be proven. Although there were no complications in this specified 245 
period, long term follow up will be helpful for monitoring complications. In our 246 
practice, patients travel from far and wide and find it difficult to attend routine 247 
face to face follow up appointment. We did manage to communicate with all the 248 
patients to establish that none of them needed further intervention (either 249 
surgical or medical including use of oral antibiotics) for suspected infection in 250 
either of the replaced knees.   251 
 252 
One key strength of this study is patients undergoing simultaneous bilateral TKAs 253 
for end-stage OA under the same anaesthetic by the same surgical team using 254 
identical technique and implants in both the knees. This has minimized the effect 255 
of potential confounders and allowed us to conduct a meaningful comparison. 256 
 257 
 258 
Conclusion: 259 
 260 
Addition of Methylprednisolone to periarticular infiltration cocktail in patients 261 
undergoing total knee arthroplasty has significant influence on reduction of pain 262 
in early postoperative period. It also helps patients to regain knee range of 263 
motion quickly and thus may help in reducing length of stay. Longer follow up is 264 
12 
 
required to assess if these advantages are maintained in the long-term and also if 265 
indeed any of the patients develop any possible complications. 266 
 267 
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Tables: 
Table 1: Periarticular infiltration cocktail 
Details  Solution in ml used in 
each knee in patients 
with weight < 70 KGs 
Solution in ml used in 
each knee in patients 
with weight ≥ 70 KGs  
Ropivacaine (0.75%) 40 54 
Clonidine(150mg/ml) 0.6 0.8 
Adrenaline 0.3 0.3 
Ketorolac(30 mg) 2 2 
Normal Saline (0.9%) 57 63 
TOTAL (Both Knees) 100 (50ml for each 
knee)* 
120 (60 ml for each 
knee)* 
 
* After preparation of the solution for peri-articular infiltration for each 
patient, the solution was divided into two equal parts. 40 mg of 
methylprednisolone was added to the first half of the solution which was used 
for the peri-articular infiltration in the first knee (Group S) and the second half 
of the solution was used for the peri-articular infiltration in the second knee 
(Group C). 
 
 
Tables (Number each one)
 Table 2: Preoperative FFD, flexion and operative tourniquet time comparison 
 
Group Mean FFD in 
degrees (range, 
SD) 
P 
value 
Mean Flexion in 
degrees (range, 
SD) 
P  Mean 
tourniquet time 
(Minutes) 
P 
value 
Group S 7.8 (range: -5 to 
30, SD 7.18) 
 
0.44 
107.2 (range:60 
to 140, SD 16.66) 
 
0.47 
51.54 (range: 36 
to 80, SD 10.24) 
 
0.97 
Group C 7.2 (range: -10 
to 20, SD 5.72) 
108 (range:70 to 
140, SD 16.28) 
51.48 (range: 38 
to 70, SD 7.75) 
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